Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06617052
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-18
Brief Title:
Preoperative ChemoRadiotherapy for Locally Recurrent Rectal Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Efficacy and Safety of Preoperative ChemoRadiotherapy for Locally Recurrent Rectal Cancer A Prospective Single-arm Observational Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Through an observational study the efficacy and safety of preoperative chemoradiotherapy followed by surgery in patients with recurrent rectal cancer were assessed The primary population included patients with potentially resectable locally recurrent rectal cancer excluding those with distant metastases The study design was a prospective open-label single-arm observational study The primary endpoint was the pCR pathological complete response rate while secondary endpoints included R0 resection rate local recurrence-free survival overall survival and safety
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None